Dashboard
Portfolios
Watchlist
Community
Discover
Screener
YY
yygchong
Community Contributor
Followers
0
Total number of followers
Comments
0
Total number of comments
Member Since
2021
Date joined
Kyverna Therapeutics
YY
yygchong
Community Contributor
Kyverna Bull Case
Kyverna has the most experienced and proven leadership team to bring CAR-T products to market (Former Kite exectuvies running the top positons and holding board positions) of whom have experience in this new field in scaling manufacturing and marketing these products. Kyverna also has an ample funding beyond most of its peers with a runway well into 3 years without additional fundraising or milestone payments.
View narrative
US$35.00
FV
93.5% undervalued
intrinsic discount
0%
Revenue growth p.a.
Set as Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 months ago
author updated this narrative